A company that makes two opioid drugs that are administered by applying a patch to the inside of the cheek is touting the potential addition of its products to Ohio’s workers’ compensation drug formulary.
BioDelivery Sciences International Inc. makes Belbuca, an inside-the-cheek buprenorphine film, and Bunavail, a buprenorphine-and-naloxone film.
The Ohio Bureau of Workers’ Compensation has proposed adding Belbuca to the formulary as a long-acting opioid, without restrictions. Bunavail would be added to the formulary and covered in claims with an allowed condition for opioi...
Comments